Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TMG’S TRUTH MEDIA AGENCY PUBLISHES “THE STATE OF PROGRAMMATIC ADVERTISING” MARKET RESEARCH

LONDON: 8 January 2018, TRUTH , the first global blockchain-enabled media agency, today announces the findings of research conducted in collaboration with London Research. The research is based on interviews with senior marketers at well-known brands and a global survey of more than 100 senior executives with responsibility for ad buying — and highlights the crisis in confidence that is undermining the programmatic advertising industry. The full version can be found at https://truth.agency/truth_pdf.pdf Key findings: A lack of value chain transparency as 79%

Vator Securities appoints Lars Hevreng as Head of Research

Vator Securities announced today that Lars Hevreng has been appointed as Head of Research and Senior Equity Partner with the firm. Prior to joining Vator Securities, Hevreng served as a top ranked healthcare analyst at major financial institutions such as SEB and most recently Danske Bank.Hevreng is one of Sweden’s highest ranked healthcare analysts, covering companies such as AstraZeneca, Sobi and Elekta. He has also covered Recipharm, Lifco and recently Medicover, when these companies went public. The position as Head of Research at Vator Securities implies that Hevreng will lead the

Oncology Venture receives approx. SEK 740 000 through exercise of warrants of series 2015/2018

Oncology Venture Sweden AB (”Oncology Venture”) announces that CFO Nikolaj Buhl Jensen has exercised 100 000 warrants of series 2015/2018, meaning that 107,000 shares are issued for a share price of SEK 6.88 per share. Oncology Venture thus receives SEK 740,000 through the exercise of warrants of series 2015/2018. A total of 70,000 warrants of series 2015/2018 remains in ”Optionsprogram 1” after the exercise of warrants by Nikolaj Buhl Jensen. The warrant terms concerning warrant exercising have been adjusted as a result of the rights issue that was conducted during the spring 2017, which

Dallas picks Ericsson for smart cities traffic solution

· Adoption of Ericsson’s Connected Urban Transport solution will help ease traffic congestion · Ability to share data across cities and counties to make roads safer for commuters · Will improve the connection of systems to increase efficiency and reduce costsThe City of Dallas has selected Ericsson (NASDAQ: ERIC) to install and host an Advanced Traffic Management System (ATMS) based on Ericsson’s Connected Urban Transport solution. The city’s vision for the traffic system is an intuitive and easy-to-use interface that automates and facilitates system monitoring, management,

Tokmanni Group Corporation: Notification of Manager’s Transactions

Tokmanni Group Corporation Stock exchange release   8 January 2018 at 9:00 (EET) Person subject to the notification requirement Name:                                      Takoa Invest Oy Position:                                  Closely associated legal person Person discharging managerial responsibilities in issue Name:                                     Saastamoinen Seppo Markku Position:                                 Member of the Board ____________________________________________________________________ Notification Type:                      Initial

The diabetes vaccine Diamyd® shows continued positive clinical course after 30 months

Positive effects such as lower insulin requirements and improved blood glucose levels are observed for the first four diabetes patients that have been followed for 30 months in the DIAGNODE-1 trial. Safety looks good and no serious side effects have been reported.In a fifth interim report from the open label investigator initiated clinical pilot trial DIAGNODE-1, where the diabetes vaccine Diamyd® is administered directly into the lymph node, results are presented for the first four patients that have been followed for the entire study period, 30 months. No serious side effects have been

SOTKAMO SILVER CONTINUES TO INVEST IN THE SILVER MINE - AGREEMENT ON MILL DELIVERY

Sotkamo Silver has entered into an agreement with Outotec (Finland) Oy on the delivery of a grinding mill circuit to the Silver Mine project, which is under construction in Central Eastern Finland. The mills will have a capacity of 450,000 tonnes of ore per year in full production. Outotec which will be responsible for delivery, is a world-leading mining technology company. According to the agreement, both mills in the grinding circuit will be delivered during autumn 2018. With the agreement, the Company continues to invest in the Silver Mine project, and together with the already

Tokmanni Group Corporation: Notification of Manager’s Transactions

Tokmanni Group Corporation Stock exchange release   8 January 2018 at 9:00 (EET) Person subject to the notification requirement Name:                                     Rockers Tukku Oy Position:                                 Closely associated legal person Person discharging managerial responsibilities in issue Name:                                    Saastamoinen Seppo Markku Position:                                 Member of the Board ____________________________________________________________________ Notification Type:                       Initial

Skanska builds graduate student housing in San Francisco, USA, for USD 170M, about SEK 1.5 billion

Skanska has signed a contract with the University of California, San Francisco (UCSF) to build two buildings of graduate student housing in San Francisco, USA. The contract is worth USD 170M, about SEK 1.5 billion, which will be included in the US order bookings for the fourth quarter 2017.The project in the city’s Mission Bay neighborhood will consist of 36,200 square meters of housing that will include nearly 600 units that can accommodate up to 810 medical students and trainees. One building will be six levels including one level of on-grade parking. The other will be six levels plus one

Japanese credit card company Credit Saison signs agreement for Cxense software

Oslo, Norway – 8 January 2017 – Cxense ASA (OSE: CXENSE) today announced that Credit Saison Co., Ltd, one of Japan’s biggest credit card issuers, signed an agreement with Cxense for use of data management and personalization software.Tokyo-based Credit Saison provides services related to credit, leasing, finance, real estate and entertainment both domestically and internationally. The company offers credit- and prepaid cards, loan collection agency services and corporate cards. Credit Saison issues cards carrying American Express, Visa, Mastercard or JCB brands and has about 27 million

Successful completion of pre-clinical safety studies with MIV-818, enabling start of phase I clinical studies in 2018

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced the successful completion of the pre-clinical safety studies for MIV-818 to enable the start of phase I clinical trials in 2018.MIV-818 is Medivir’s proprietary liver-targeted nucleotide prodrug for the treatment of hepatocellular carcinoma (HCC) and other forms of liver cancer. It is the first development project to emerge from Medivir’s in-house drug discovery efforts in oncology. With the successful completion of the pre-clinical safety studies on MIV-818, Medivir intends to make the necessary regulatory

Meet Senzime at Arab Health in Dubai, 29th January – 1st February

News; Uppsala, January 8, 2018. Arab Health is the largest gathering of healthcare and trade professionals in the MENA region. The 2018 edition of the event is expected to welcome more than 4,200 exhibiting companies and 103,000 attendees from 150+ countries.   Senzime will be exhibiting our products inthe Swedish Pavilion, Za’abeel Hall 1, stand Z1.A50 "We are experiencing a large interest for our products from the MENA region. Participating at Arab Health gives us the opportunity to connect with different decision makers and distributors from the area visiting the show",

Tokmanni Group - Correction to announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Tokmanni Group Corporation (the “Company”) has received a notification from Takoa Invest Oy according to which Takoa Invest Oy's 100% owned subsidiary, Rockers Tukku Oy, has been merged with its parent company Takoa Invest Oy on 31 December 2017 and thus Rockers Tukku’s 17.00% direct holding in Tokmanni Group has been transferred to Takoa Invest Oy. In the release sent earlier today there was a mistake in the title of the table below. The correct title is: Total positions of Takoa Invest Oy: +-----------------+---------+------------------+-----+------------------------+|

Tokmanni Group Corporation - Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Tokmanni Group Corporation (the “Company”) has received a notification from Takoa Invest Oy according to which Takoa Invest Oy's 100% owned subsidiary, Rockers Tukku Oy, has been merged with its parent company Takoa Invest Oy on 31 December 2017 and thus Rockers Tukku’s 17.00% direct holding in Tokmanni Group has been transferred to Takoa Invest Oy. Total positions of Rockers Tukku Oy: +-----------------+---------+------------------+-----+------------------------+| |% of   |% of   shares and |Total|Total   number of shares|| |shares |voting

GHP starts new business within Urology

In order to strengthen its position within urology in Stockholm, GHP is starting a urology clinic at Läkarhuset Odenplan in Stockholm. The clinic will be led by Magnus Annerstedt, who is verymuch involved in the field of urology both nationally and internationally and who has state of the art competence in prostate cancer care and robotic surgery. GHP already has Urologcentrum in Liljeholmen in the south of Stockholm. The new clinic at Odenplan will supplement this with a catchment area comprising the center and north of Stockholm.GHP Urologcentrum Odenplan starts on 1 February 2018 and

Board Appointment

ENQUEST PLC, 8 January 2018.Board Appointment EnQuest PLC ('EnQuest') is pleased to announce the appointment of Laurie Fitch as a Non-Executive Director of the EnQuest Board with effect from 8 January 2018. On joining the Board, Laurie Fitch will become a member of the Remuneration and Risk Committees. Laurie has developed an extensive knowledge of the utilities and industrials sectors having worked for more than 20 years in a variety of investment and corporate finance roles. She is currently a partner in the Strategic Advisory Group of PJT Partners. Ms. Fitch is also a member of

BerGenBio to present at Biotech Showcase 2018

Bergen, Norway, 8 January 2018 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces that the Company will present a corporate update during the Biotech Showcase 2018 held at the Hilton San Francisco Union Square. The presentation will include a discussion of recent progress across BerGenBio’s phase II clinical trial programme with selective Axl inhibitor BGB324 (bemcentinib).Details of the presentation are as follows: · Date: January 9, 2018 · Time: 10:00 am PST · Room:

CELLINK signs collaboration agreement with CTIBIOTECH for Bioprinting of patient-specific cancer tumors

CTIBIOTECH are leading a new path towards personalized cancer therapies through utilization of CELLINK’s technology platform. By taking a small piece of a patient’s tumor, multiplying the cells, and then bioprinting the patient’s tumor in the laboratory, researchers can discover, understand and find the exact treatment best for the specific cancer. CTIBIOTECH uses 3D bioprinting technologies, including the CELLINK BIO X 3D printing system and bioinks, to advance models and lead the way forward for treating cancer in the future. Professor Colin McGuckin (Founder, CTIBIOTECH) “We are proud

Revenues for the fourth quarter of 2017

Lier, 8 January 2018: Kid ASA today announces unaudited revenue figures for the fourth quarter of 2017 (previous year in brackets). For definition of like-for-like stores, please see latest quarterly report at http://investor.kid.no. · Q4 revenues increased by +4.5% to MNOK 505.5 (MNOK 483.8). Like-for-like sales decreased by -0.2%. Online sales increased by +33.8%. The number of shopping days in the quarter was 76 (78). · For the fiscal year of 2017, revenues increased by +6.8% to MNOK 1,381.7 (MNOK 1,293.9). Like-for-like sales increased by +3.1%. Online sales increased by +35.4%.

Cimco Marine AB (publ) launches 150 hp OXE – production of 200 hp OXE is expected to resume in Q2

Cimco Marine AB (publ) will commence production and delivery of the 150 hp OXE diesel outboard engine this week. During the autumn, the company has worked hard to finalise the 150 hp model. The response from our distributors has been positive.Separately, the root cause for the turbo leakage in the 200 hp OXE has been identified. The production of 200 hp OXE is expected to recommence in Q2.– The launch of 150 hp OXE has been well received by our distributors and end customers. Some of our customers are to convert their 200 hp OXE orders to 150 hp OXE. Overall, of course, it is very

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

Oslo, Norway, 8 January 2018: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Michael Bogenstaetter has been appointed as the Company's Chief Business Officer (CBO). He will take up this role in January 2018. Michael joins Targovax following 25 years' experience in biotech and big pharma. During this time he held senior business development and strategy positions with Sanofi, Novartis and MDS. Michael has also worked as a consultant with The Boston Consulting Group and,

Scientists uncover why sauna bathing is good for your health

Over the past couple of years, scientists at the University of Eastern Finland have shown that sauna bathing is associated with a variety of health benefits. Using an experimental setting this time, the research group now investigated the physiological mechanisms through which the heat exposure of sauna may influence a person’s health. Their latest study with 100 test subjects shows that taking a sauna bath of 30 minutes reduces blood pressure and increases vascular compliance, while also increasing heart rate similarly to medium-intensity exercise. Previously, the research group has

Millicom acquires spectrum in Paraguay

Luxembourg, January 5th, 2018 - Millicom International Cellular S.A. ("Millicom") announced today that its wholly-owned subsidiary in Paraguay, Telefónica Celular del Paraguay SA (Tigo), has acquired three of the seven available blocks of 2x5MHz spectrum in the 700MHz band at a total cost of $36.325m, plus certain social and network coverage obligations.  Jose Perdomo, General Manager of Tigo Paraguay, commented: “This new spectrum will allow us to cost-effectively continue to expand our 4G network in Paraguay and provide high-speed mobile data services to more Paraguayans. We are proud

Citycon Oyj - Changes in company's own shares

CITYCON OYJ  Stock Exchange Announcement05.01.2018 at 18:35 hrs REPURCHASE OF OWN SHARES Date: 5.1.2018Exchange transaction: Buy Share class CTY1SAmount, shares 30 000Average price/share, EUR 2,1950Total price, EUR 65 850,00 The number of shares heldby Citycon Corporationafter the completion oftransactions: 30000shares. On behalf of CityconCorporation EVLI BANK PLC Lauri Vehkaluoto Further Enquiries: Head of InvestorRelations, Mikko PohjalaTel. +358 40 838

There are no items matching the current filter
There are no more items matching the current filter
Back to top